These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12034442)

  • 1. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.
    Schlehuber S; Skerra A
    Biophys Chem; 2002 May; 96(2-3):213-28. PubMed ID: 12034442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin.
    Schlehuber S; Beste G; Skerra A
    J Mol Biol; 2000 Apr; 297(5):1105-20. PubMed ID: 10764576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural mechanism of specific ligand recognition by a lipocalin tailored for the complexation of digoxigenin.
    Korndörfer IP; Schlehuber S; Skerra A
    J Mol Biol; 2003 Jul; 330(2):385-96. PubMed ID: 12823976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold.
    Schlehuber S; Skerra A
    Biol Chem; 2001 Sep; 382(9):1335-42. PubMed ID: 11688717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold.
    Beste G; Schmidt FS; Stibora T; Skerra A
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1898-903. PubMed ID: 10051566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Anticalins': a new class of engineered ligand-binding proteins with antibody-like properties.
    Skerra A
    J Biotechnol; 2001 Jun; 74(4):257-75. PubMed ID: 11526907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of ribosome display library based on lipocalin scaffold and screening anticalins with specificity for estradiol.
    Liu J; Ning B; Liu M; Sun Y; Sun Z; Zhang Y; Fan X; Zhou Z; Gao Z
    Analyst; 2012 May; 137(10):2470-9. PubMed ID: 22489281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticalins small engineered binding proteins based on the lipocalin scaffold.
    Gebauer M; Skerra A
    Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
    Korndörfer IP; Beste G; Skerra A
    Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.
    Vopel S; Mühlbach H; Skerra A
    Biol Chem; 2005 Nov; 386(11):1097-104. PubMed ID: 16307475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.
    Rauth S; Hinz D; Börger M; Uhrig M; Mayhaus M; Riemenschneider M; Skerra A
    Biochem J; 2016 Jun; 473(11):1563-78. PubMed ID: 27029347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of anticalins with specificity for a nonsymmetric phthalic acid ester.
    Mercader JV; Skerra A
    Anal Biochem; 2002 Sep; 308(2):269-77. PubMed ID: 12419339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D.
    Vogt M; Skerra A
    Chembiochem; 2004 Feb; 5(2):191-9. PubMed ID: 14760740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
    Gebauer M; Schiefner A; Matschiner G; Skerra A
    J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and/or therapy.
    Eggenstein E; Eichinger A; Kim HJ; Skerra A
    J Struct Biol; 2014 Feb; 185(2):203-14. PubMed ID: 23542582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalins as a scaffold.
    Skerra A
    Biochim Biophys Acta; 2000 Oct; 1482(1-2):337-50. PubMed ID: 11058774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticalins directed against vascular endothelial growth factor receptor 3 (VEGFR-3) with picomolar affinities show potential for medical therapy and in vivo imaging.
    Richter A; Skerra A
    Biol Chem; 2017 Jan; 398(1):39-55. PubMed ID: 27458663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticalins Reveal High Plasticity in the Mode of Complex Formation with a Common Tumor Antigen.
    Schiefner A; Gebauer M; Richter A; Skerra A
    Structure; 2018 Apr; 26(4):649-656.e3. PubMed ID: 29526433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticalins versus antibodies: made-to-order binding proteins for small molecules.
    Weiss GA; Lowman HB
    Chem Biol; 2000 Aug; 7(8):R177-84. PubMed ID: 11048945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.